Literature DB >> 30417033

Assessment and Treatment Strategies for a Multiple Sclerosis Relapse.

Cynthia Wang1,2, America Ruiz1,2, Yang Mao-Draayer2.   

Abstract

Relapses are the hallmark features of relapsing-remitting multiple sclerosis (RRMS). True relapses may be challenging to accurately diagnose. A clinician must rely on a combination of history, exam findings, laboratory studies, and neuroimaging to decide whether or not to treat for a presumed relapse. Although many consider MRI as the gold standard diagnostic test, it may not be rapidly accessible and still could miss lesions. In light of this diagnostic complexity, future directions including development and validation of a scale to assess MS relapse probability and severity would be useful to multiple sclerosis specialists and practicing neurologists. Given the complex pathophysiology of MS, more research is needed to ascertain the validity of promising biomarkers for predicting relapse.

Entities:  

Year:  2016        PMID: 30417033      PMCID: PMC6223639     

Source DB:  PubMed          Journal:  J Immunol Clin Res        ISSN: 2333-6714


  29 in total

1.  Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS.

Authors:  E Waubant; L Gee; P Bacchetti; R Sloan; A Cotleur; R Rudick; D Goodkin
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

2.  Scoring treatment response in patients with relapsing multiple sclerosis.

Authors:  M P Sormani; J Rio; M Tintorè; A Signori; D Li; P Cornelisse; B Stubinski; M l Stromillo; X Montalban; N De Stefano
Journal:  Mult Scler       Date:  2012-09-25       Impact factor: 6.312

Review 3.  What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.

Authors:  A Finkelsztejn; J B B Brooks; F M Paschoal; Y D Fragoso
Journal:  BJOG       Date:  2011-03-15       Impact factor: 6.531

4.  Risk of relapse phenotype recurrence in multiple sclerosis.

Authors:  Tomas Kalincik; Katherine Buzzard; Vilija Jokubaitis; Maria Trojano; Pierre Duquette; Guillermo Izquierdo; Marc Girard; Alessandra Lugaresi; Pierre Grammond; Francois Grand'Maison; Celia Oreja-Guevara; Cavit Boz; Raymond Hupperts; Thor Petersen; Giorgio Giuliani; Gerardo Iuliano; Jeannette Lechner-Scott; Michael Barnett; Roberto Bergamaschi; Vincent Van Pesch; Maria Pia Amato; Erik van Munster; Ricardo Fernandez-Bolanos; Freek Verheul; Marcela Fiol; Edgardo Cristiano; Mark Slee; Maria Edite Rio; Daniele Spitaleri; Raed Alroughani; Orla Gray; Maria Laura Saladino; Sholmo Flechter; Joseph Herbert; Jose Antonio Cabrera-Gomez; Norbert Vella; Mark Paine; Cameron Shaw; Fraser Moore; Steve Vucic; Aldo Savino; Bhim Singhal; Tatjana Petkovska-Boskova; John Parratt; Carmen-Adella Sirbu; Csilla Rozsa; Danny Liew; Helmut Butzkueven
Journal:  Mult Scler       Date:  2014-04-28       Impact factor: 6.312

5.  The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.

Authors:  Antonio Scalfari; Anneke Neuhaus; Alexandra Degenhardt; George P Rice; Paolo A Muraro; Martin Daumer; George C Ebers
Journal:  Brain       Date:  2010-06-09       Impact factor: 13.501

6.  High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.

Authors:  L Durelli; D Cocito; A Riccio; C Barile; B Bergamasco; G F Baggio; F Perla; M Delsedime; G Gusmaroli; L Bergamini
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

Review 7.  Progressive Multiple Sclerosis.

Authors:  Mary Alissa Willis; Robert J Fox
Journal:  Continuum (Minneap Minn)       Date:  2016-06

Review 8.  Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.

Authors:  F Sellebjerg; T L Sørensen
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Differential micro RNA expression in PBMC from multiple sclerosis patients.

Authors:  David Otaegui; Sergio E Baranzini; Ruben Armañanzas; Borja Calvo; Maider Muñoz-Culla; Puya Khankhanian; Iñaki Inza; Jose A Lozano; Tamara Castillo-Triviño; Ana Asensio; Javier Olaskoaga; Adolfo López de Munain
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more
  3 in total

1.  Evaluation of Urinary Tract Infection following Corticosteroid Therapy in Patients with Multiple Sclerosis Exacerbation.

Authors:  Aliyeh Bazi; Seyed Mohammad Baghbanian; Monireh Ghazaeian; Sahar Fallah; Narjes Hendoiee
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-01-31       Impact factor: 2.471

2.  Measuring treatment response to advance precision medicine for multiple sclerosis.

Authors:  Peter A Calabresi; Ludwig Kappos; Gavin Giovannoni; Tatiana Plavina; Irene Koulinska; Michael R Edwards; Bernd Kieseier; Carl de Moor; Elias S Sotirchos; Elizabeth Fisher; Richard A Rudick; Alfred Sandrock
Journal:  Ann Clin Transl Neurol       Date:  2021-10-26       Impact factor: 4.511

3.  Methylprednisolone-Induced Symptomatic Sinus Bradycardia in a Multiple Sclerosis Patient: A Case Report.

Authors:  Mohammed A Miqdad; Abdullah Mohamad; Fawaz Ali; Abdul Rahman Mourad; Abdullah Alamri
Journal:  Cureus       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.